Dual targeting of HSP90 and BCL-2 in breast cancer cells using inhibitors BIIB021 and ABT-263. Goksen Tosun N, Kaplan O. Breast Cancer Res Treat 2025 Jan 9. doi: 10.1007/s10549-024-07587.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Goksen Tosun N, Kaplan O. Dual targeting of HSP90 and BCL-2 in breast cancer cells using inhibitors BIIB021 and ABT-263. Breast Cancer Res Treat 2025 Jan 9. doi: 10.1007/s10549-024-07587.
PMID: 39779635